The impact of a multi-micronutrient nutritional formula combined with cognitive behavioral therapy in managing symptoms of children with attention deficit hyperactivity disorder
- PMID: 40692802
- PMCID: PMC12277375
- DOI: 10.3389/fped.2025.1624344
The impact of a multi-micronutrient nutritional formula combined with cognitive behavioral therapy in managing symptoms of children with attention deficit hyperactivity disorder
Abstract
Background: Attention-Deficit/Hyperactivity Disorder (ADHD) characterized by symptoms of inattention, hyperactivity, and impulsivity, with substantial impacts on a child's academic performance, social interactions, and overall quality of life. This study investigates the impact of combining a multi-micronutrient nutritional formula (MNF) with cognitive behavioral therapy (CBT) in managing ADHD symptoms in children.
Methods: In a retrospective analysis of 220 children aged 6-14 years diagnosed with ADHD, patients were divided into two groups: the MNF group (n = 112) receiving only the nutritional formula, and the MNF-CBT group (n = 108) receiving both the nutritional formula and CBT. The interventions were conducted over three months. Outcomes were measured using the Conners Parent Symptom Questionnaire (PSQ), SNAP-IV Teacher Form, and Dundee Difficult Times of the Day Scale (D-DTODS).
Results: Both groups were comparable at baseline in terms of demographics and ADHD symptom severity. Post-treatment analyses revealed greater reductions in attention deficit scores, hyperactivity/impulsivity scores, and oppositional symptoms scores in the MNF-CBT group compared to the MNF group. Conduct scores were lower in the MNF-CBT group than in the MNF group, and learning scores also showed a similar pattern of reduction. Functional impairments across various daily activities, as measured by the D-DTODS, were also reduced in the MNF-CBT group. No adverse events or safety concerns were observed during the intervention period.
Conclusion: The combination of multi-micronutrient supplementation with CBT shows potential in alleviating both neurochemical deficiencies and behavioral dysregulation in children with ADHD. These findings suggest that this integrated approach may be beneficial for managing ADHD symptoms.
Keywords: ADHD; attention-deficit/hyperactivity disorder; cognitive behavioral therapy; multi-Micronutrient supplementation; pediatric psychology.
© 2025 Wang and Cao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Methylphenidate for children and adolescents with autism spectrum disorder.Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2. Cochrane Database Syst Rev. 2017. PMID: 29159857 Free PMC article.
-
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
-
Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2018 Mar 23;3(3):CD010840. doi: 10.1002/14651858.CD010840.pub2. Cochrane Database Syst Rev. 2018. PMID: 29566425 Free PMC article.
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2023 Mar 27;3:CD009885. doi: 10.1002/14651858.CD009885.pub3. PMID: 26599576 Free PMC article. Updated.
-
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2023 Apr 14;4:CD007986. doi: 10.1002/14651858.CD007986.pub3. PMID: 22786509 Free PMC article. Updated.
References
-
- Zhou Z, Betts KA, Bocharova I, Kinrich D, Spalding WM. Concomitant use of psychotropic medication with stimulants for the treatment of ADHD in children and adolescents: a retrospective insurance claims study in the United States. J Atten Disord. (2020) 24(2):336–47. 10.1177/1087054718784668 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources